Widespread Genetic Heterogeneity in Multiple Myeloma: Implications for Targeted TherapyJens G. Lohr, Keith Stockerl-Goldstein, Petar Stojanov et al.|Cancer Cell|2014Cited by 1k
Comparison of bivalent and monovalent SARS-CoV-2 variant vaccines: the phase 2 randomized open-label COVAIL trialAngela R Branche, Kuleni Abebe, Susan J. Little et al.|Nature Medicine|2023Cited by 56
SARS-CoV-2 Variant Vaccine Boosters Trial: Preliminary AnalysesAngela R Branche, Kuleni Abebe, Nadine Rouphael et al.|medRxiv|2022Cited by 30
Risk of COVID-19 after natural infection or vaccinationAnne-Marie Rick, Priyantha N. Wijewardane, Jennifer Winbigler et al.|EBioMedicine|2023Cited by 14